- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Why state dental boards are scrutinizing DSOs
- 6 dental leadership moves to know
- Dr. Paul Jacobs installed as president of the American Academy of Dental Sleep Medicine
- AI is finding cancer earlier. Are systems ready for what comes next?
- UPMC to buy system from CommonSpirit, enter Ohio: 6 things to know
- Ohio hospital pilots AI alerts for heart care
- Medical group updates pediatric critical care staffing standards
- Marshall Health Network inks historic jersey patch deal
- Judy Faulkner: Why Epic has only lost 1 customer
- The real AI gap in healthcare isn’t intelligence
- Fitch downgrades MemorialCare’s rating
- Georgia VA hospital ends inpatient services, shifts to ambulatory care center
- Physician executive to lead Penn Medicine’s Doylestown Health
- Does private practice have a growth ceiling?
- The next phase of the GLP-1 boom
- 3 physician practice, clinic closures in 1 month
- Louisiana hospital adds gastroenterology services
- Child Mind Institute names chief clinical officer
- Texas ASC operator names COO
- ECU Health performs 1st colorectal surgeries in North Carolina with da Vinci robot
- The costly mistakes ASC leaders make before they sell
- How 3 policies threaten ASCs’ anesthesia stability
- UMass Memorial behavioral health provider to lay off 78 employees
- The most overlooked issue in dentistry
- 10 spine surgeons shaping the future of ASC growth
- Massachusetts dental practice opens new $3.5M facility
- Patients of shuttered dental practice receive $1M+ in refunds
- Acadia Healthcare revenue rises 7.6% as net income dips: 6 notes
- New York hospital expands behavioral health capacity to 60 beds
- Real estate firm acquires 2 ASCs leased to United Digestive
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Cleveland Clinic to establish pediatric behavioral health program
- New Hampshire methadone clinic operator faces federal scrutiny
- North Carolina weighs dental board reform bill
- 9 dentists making headlines
- ASCQS releases second annual ASC quality survey
- American Hospital Association, West Health Institute partner to help health systems scale new tech
- Alignment CEO expects short delay for CMS' proposed risk adjustment changes
- WakeMed Health's plans to join Atrium Health face swift pushback from NC officials
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- How Headspace fully automates complex eligibility workflows with AI agents
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- SCOTUS temporarily restores online access to abortion pill after appeals court ruling
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Nearly half of reproductive age women with Medicaid coverage live in states restricting abortion: KFF
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
- After March cuts, Novartis trims another 60 roles at US headquarters
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion
- Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs
- 12 new behavioral health study findings to know
- Prevention Efforts Increasingly See Suicide Through a Broader Lens
- California dental hygiene program placed on probation, accreditation at risk: 5 notes
- US depression rate remains near record high: Gallup
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- Yale receives $10M for youth mental health
- FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Omada signs on with Optum Rx's GLP-1 management program
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Industry Voices—Value-based care won the policy argument. Now it has to deliver
- Senators introduce clean extension to cost-based payments for some rural hospitals
- Beth Israel Lahey Health taps Heidi for system-wide AI scribe rollout
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Cleveland Clinic taps startup Luminai to test how AI can run hospital operations
- Look out Rexulti, Axsome's Auvelity has its nod for Alzheimer's agitation
- Cardio drug developer Esperion to go private in potential $1.1B buyout by ArchiMed
- Union workers at Korean CDMO Samsung Biologics kick off strike
- Summit's PD-1xVEGF interim trial miss surprises analysts, shares tumble
- Who do Americans believe have the most influence in healthcare?
- Health Tech Weekly Rundown: Sage launches Tasking for senior care workflows; St. Luke’s taps Auxira Health for cardiologist support
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
- Senses, Not Muscles, Key to Speech Recovery After Stroke
- Antibiotics Not Linked To Celiac Disease Risk, Study Argues
- Common Knee Surgery Doesn't Help, Might Actually Make Things Worse, Clinical Trial Reports
- States Rush To Figure Out How To Enforce Trump's Medicaid Work Requirements
- Delays in Visa Program Threaten Placement of Hundreds of Doctors in Underserved Areas
- Gavin Newsom, Early Champion of Single-Payer, Moderates in the Face of Fiscal Limits
- A pivotal time for an RNA pioneer
- Repatha sales help Amgen overcome Prolia biosimilar hits in 1st quarter
- Novo Nordisk’s Rybelsus officially retired in US as ‘Ozempic pill’ takes branding center stage
- Verastem launches ‘Reimagine’ campaign to move ovarian cancer drugs into earlier lines
- FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- Managing AI in Medical Technology: From Innovation to Compliance
- Managing AI in Medical Technology: From Innovation to Compliance
- Fierce Pharma Asia—Sun’s $11.75B Organon buy; Astellas’ Xtandi peak; BeOne’s PD-1xVEGF bet
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- DOJ launches West Coast Health Care Strike Force to target fraud in Arizona, Nevada, Northern California
- Tenet Healthcare met Q1's volume curveballs with 'old-fashioned discipline'
- FDA expectations create potential friction in new Form 483 response guidance
- Trump pulls surgeon general nomination of Casey Means, names Nicole Saphier as new pick
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Functional medicine provider Parsley Health now in-network nationwide
- Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's
- BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio
- Merck's growth products Winrevair, Ohtuvayre trending in opposite directions
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- States Rush To Figure Out How To Enforce Trump’s Medicaid Work Requirements
- Cigna to exit ACA market, pursue strategic alternatives for eviCore unit
- Rising Stars: Axplora’s Arsalan Khan gets technical on marketing
- Merck bats for heart disease awareness with new baseball-inspired campaign
- Orchestrating Affordability: The Critical New Role of the Health Plan
- The Case for a More Proactive Payment Integrity Program
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
At least it is not tax dollars at work; only the proceeds of lawfare. MDHHS is funding an opioid Harm Reduction strategy, many components of which violate local ordinances - not to mention sanity:
Community ordinances are clashing with Michigan’s drug harm reduction strategy
By Georgea Kovanis - May 13, 2024When it comes to trying to reduce the devastation that accompanies the use of illicit drugs, experts say Michigan is working against itself.
Here's what's happening: In an effort to keep people alive, the state of Michigan is funneling millions of dollars from settlements with opioid manufacturers and distributors into a strategy called harm reduction — reducing the harms associated with drug use. That means easy access to Narcan, which can reverse an opioid overdose if given quickly and correctly. It also means reducing the spread of infectious disease by providing clean syringes to intravenous drug users. And it means providing kits to test drugs for the presence of ultra-deadly fentanyl in street drugs.
At the same time, hundreds of local communities have paraphernalia ordinances that prohibit people from possessing or providing syringes and other supplies, including kits to test for the presence of fentanyl in street drugs. What's legal in one community may be illegal in another.
Harm reduction advocates say the local laws are compromising their efforts and punishing drug users who are trying to do what health officials advise.
"We're basically criminalizing people trying to protect their health and protect the community's health," said Steve Alsum, executive director of the Grand Rapids Red Project, a prominent harm reduction agency in west Michigan that supplies syringes and test kits. Syringe services programs "could provide more benefit to more of the community if these programs were legal state wide."
So what does this clash of laws and philosophies really mean?
And why does it matter to people who don't use drugs?
Back up, drug users can get free needles?
They can — and they can get more than that.
A variety of syringe service programs across the state, including ACCESS in Sterling Heights, the Red Project, and Harm Reduction Michigan in northern Michigan and the Families Against Narcotics' Harm:Less mobile unit, use opioid settlement money to supply needles and other harm reduction equipment to drug users.
Among those supplies: Kits to determine whether drugs contain fentanyl, the synthetic opioid that is involved in the majority of the nation's 100,000-plus overdose deaths a year, including roughly 3,000 in Michigan.
And, kits to test drugs for xylazine, a potent, non-opioid large animal tranquilizer that is most often mixed into fentanyl. Last year, Oakland County Sheriff Michael Bouchard said xylazine was present in up to 85% of the fentanyl his department seized. Because it is not an opioid, xylazine is impervious to Narcan.
To find a complete list of syringe service programs, go to rb.gy/osre70
How many needles are we talking about here?
We're talking about more and more syringes every year.
In the fourth quarter of 2023, syringe service programs across the state distributed nearly 1.2 million syringes, a 30% increase compared with the fourth quarter of 2022, accoridng to data from the Michigan Department of Health and Human Services (MDHHS).
So these syringe service programs help addicts do drugs?
They recognize the reality of drug addiction, advocates say.
Addicts are going to use whether or not they have access to clean needles; that's the nature of addiction. Shared needles promote the spread of HIV and Hepatitis C. Reusing needles promotes endocarditis, an infection that inflames the lining of the heart's valves and chambers.
According to the U.S. Centers for Disease Control and Prevention, people who participate in a syringe service program lower their risk of contracting HIV or Hepatitis C by 50%.
“Most people who inject drugs, if they have access to sterile, unusued syringes, they're going to use a sterile, unused syringe each and every time they inject," said Alsum. "The reason people share or reuse syringes is there's a lack of access to them caused by the criminalization of that tool."
In addition, research shows people who participate in syringe service programs are five times more likely to seek treatment for their addiciton than are those who do not participate in needle exchange programs.
And because fentanyl and xylazine have infiltrated street drugs, providing kits to test for the presence of those substances, can save lives. They may still use their fentanyl or xylazine-laced drugs, but they may choose to use at a slower pace or choose to use in the presence of someone who can call for help if they overdose.
Not everyone agrees with this approach. Opponents argue that passing out clean needles only enables drug use. Opponents also argue that there's a reason paraphernalia laws are on the books: drugs are dangerous and a menace to society.
A change of leadership in the Eastpointe Police Department shut down the Harm:Less syringe service mobile unit late last year. It had been operating at the intersection of Eight Mile and Gratiot for some time.
Eastpointe Police Chief Corey Haines directed Free Press questions about the decision to City Council.
"We are relying upon the in depth expertise of our Chief of Police to ensure that the health, welfare and safety of our residents, businesses and visitors are prioritized," said Assistant City Manager Kim Homan. "Properties at the Gratiot and 8 Mile Road's intersection reflect an important entrance to our city."
What's so difficult about obeying the law?
When it comes to syringes and other drug paraphernalia, laws aren't consistent.
"Every city has this patchwork of ordinances," said Andrew Coleman, who runs harm reduction programs for ACCESS (the Arab Community Center for Economic and Social Services), which has offices in Sterling Heights and Dearborn.
Sterling Heights, for example, allows syringes and parapheranalia for illicit drug use as long as they are distributed by a recognized health authority with the aim of stopping the spread of innfectious disease. As a result, ACCESS is able to give out syringes in that community.
But Dearborn outlaws the posession and use of all syringes and paraphernalia related to illicit drugs ― even if they come from a legitimate harm reduction agency, which mean ACCESS is not allowed to provide syringes in that city.
Lincoln Park, which has one of the highest rates of drug overdose deaths in the state, also outlaws them. It also considers products designed to test drugs, such as fentanyl test strips, as paraphernalia.
In Flint, which also has one of the highest overdose death rates in the state, it's illegal to give away, furnish or display hypodermic needles or any other device designed or adapted for drug use, although those rules do not apply to participants of the Wellness AIDS Service Incorporated Approved Syringe Exchange Program.
In Detroit, paraphernalia, including syringes and test strips, are illegal unless provided by an authorized syringe exchange program.
So what's legal in one community isn't necessarily legal in another.
The state has a law, too: Selling syringes is illegal, unless they're sold by an agency authorized to reduce the transmission of infectious disease; except those agencies don't sell syringes, they give them away.
“It seems kind of crazy to have really begun to encourage these programs but not have that issue taken care of," said Pam Lynch, director of Harm Reduction Michigan, which is based in Traverse City and Petoskey, but does work throughout the state.
For fiscal year 2024, the state allocated $4.2 million of opioid settlement money for syringe service programs, according to MDHHS.
Why can't people just drive to where paraphernalia is legal and get it there?
They can. But possessing syringes or driving with them in communities where they are not legal can still result in criminal charges.
In most cases the maximum punishment is a $500 fine and/or 90 days in jail.
But for someone who is already on probation, an additional charge can mean a probation violation, which can result in more sanctions.
In addition, harm reduction workers who distribute the syringes or other outlawed paraphernalia could be charged with possessing or supplying contraband.
And Lynch pointed to another issue:
Syringe service programs also dispose of used syringes. Used syringes contain residue or small amounts of illicit drugs and having one of those could lead to a drug posession charge.
As a result, Lynch said, drug users "are disincentivized to return used syringes … they're disincentivized to take those public health measures. … By people not being able to use sterile equipment to prevent disease and return it safely, (the state is) kind of working against itself."
I don't do drugs, why should care about this?
There's the humanitarian aspect.
But there's also the financial aspect.
"The longer term, the bigger picture outcomes of paraphernalia ordinances are increased services at emergency departments, increased services for HIV," said Lynch.
From 2002-2012, U.S. hospitalizations for drug-related infections cost more than $700 million a year, according to research cited by the CDC. And that was before, the opioid epidemic and the intravenous drug use that it fostered reached fever pitch.
The most common payer for those hospitalizations: Medicaid, which is partly funded by state taxpayers.
Meanwhile, in 2017, opioid addiction alone cost the United States $1 trillion in health care, treatment, incarceration, lost productivity and reduced quality of life, according to the CDC.
Will the state make its rules consistent across Michigan?
Last year, state Rep. Carrie Rheingans, D-Ann Arbor, introduced a pair of bills that, if passed by Lansing lawmakers and signed by Gov. Gretchen Whitmer, would alleviate the concerns of harm reduction advocates.
House Bill 5178 would decriminalize the posession or distribution of needles, hypodermic syringes or drug paraphernalia aimed at reducing the spread of infectious disease by who those who work at legitimate syringe exchange programs and for those who participate in them. The bill would also decriminalize controlled substance contained in a used needle, hypodermic or drug paraphernalia if the amount of the substance is an amount sufficient only for personal use. The rules set forth in the bill would supercede all local ordinances.
House Bill 5179 would legalize products used to determine whether a controlled substance includes adulturants, including but not limited to fentanyl kits.
Rheingans, who holds dual master's degrees in public health and social work, had previously worked in HIV outreach and needle exchange.
“People in the general public and my colleagues look at it as a way to let people keep using and injecting drugs." she said. "People don’t understand that it’s a good public health measure.”
Two questions:
1) What plans are there to safely dispose of the annual 5 million sharps across Michigan? Will they pave the streets and sidewalks of Michigan? This amount of randomly discarded medical waste should make a great Pure Michigan ad.
2) When do diabetics get free needles? They seem like a deserving group.
Question 2 is a good one - diabetics have a bona fide medical condition; drug addicts start out with a choice to do something harmful.
I truly believe these programs enable drug use by providing drug users with the supplies they need.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














